Skip to main content

J&J And DePuy To Settle Pinnacle Hip Implant Lawsuits

J&J And DePuy To Settle Pinnacle Hip Implant Lawsuits

J&J And DePuy To Settle Pinnacle Hip Implant Lawsuits

Introduction

Johnson & Johnson and its DePuy Orthopaedics unit are about to resolve a large number of lawsuits targeted at their metal-on-metal Pinnacle hip implants.

Plaintiff lawyer Mark Lanier told that the consumers and the company had agreed on a settlement term to resolve the long-running hip implant litigation which holds more than 10,000 lawsuits. Though the settlement plan has not reached the final stage, it can be expected by the end of this year. Last month, J&J agreed to settle deceptive marketing claims filed by 46 U.S. states over the defective nature of the implants. The defendants denied admitting liability of misconduct linked to the claims filed. Metal-on-metal hip implants were reported to cause a build-up of metal ions in the blood resulting in groin pain, allergic reactions, and tissue death. The settlement talks caused a federal jury overlooking the case of five Texas plaintiffs, to dismiss the jury in the ongoing trial.

More than 10,400 Pinnacle hip implant lawsuits are consolidated as a part of multidistrict litigation (MDL 3:11-MD-02244, In Re: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation) overlooked by U.S. District Judge Ed Kinkeade since 2011 in the Northern District of Texas. Similar lawsuits are filed against other hip device manufacturers in the U.S. involving defendants Zimmer, Stryker, Biomet, Wright, and Smith & Nephew.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!